Atlas Venture Fund X, L.P. Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Atlas Venture Fund X, L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Atlas Venture Fund X, L.P.. Atlas Venture Fund X, L.P. is 10% Owner in AVROBIO, Inc. ($AVRO) and 10% Owner in Magenta Therapeutics, Inc. ($MGTA) and 10% Owner in Generation Bio Co. ($GBIO) and 10% Owner in Replimune Group, Inc. ($REPL) and 10% Owner in Kymera Therapeutics, Inc. ($KYMR) and 10% Owner in Ikena Oncology, Inc. ($IKNA).
Latest Insider Trading Transactions of Atlas Venture Fund X, L.P.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVRO, GBIO, IKNA, KYMR, MGTA, REPL
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 21 2021 | GBIO | Generation Bio Co. | Atlas Venture Fund X, L.P. | 10% Owner | Sell | J | 0.00 | 100,000 | 0 | 1,266,937 | 1.4 M to 1.3 M (-7.32 %) |
| Jun 21 2021 | GBIO | Generation Bio Co. | Atlas Venture Fund X, L.P. | 10% Owner | Sell | J | 0.00 | 100,000 | 0 | 1,266,937 | 1.4 M to 1.3 M (-7.32 %) |
| Jun 21 2021 | GBIO | Generation Bio Co. | Atlas Venture Fund X, L.P. | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 8,111,939 | 9.1 M to 8.1 M (-10.97 %) |
| Jun 21 2021 | GBIO | Generation Bio Co. | Atlas Venture Fund X, L.P. | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 8,111,939 | 9.1 M to 8.1 M (-10.97 %) |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | Atlas Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 5,362,888 | 0 | 0 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | Atlas Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 7,863,094 | 0 | 0 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | Atlas Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 11,258,117 | 0 | 0 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | Atlas Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 9,499,999 | 0 | 0 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | Atlas Venture Fund X, L.P. | 10% Owner | Buy | C | 0.00 | 749,634 | 0 | 749,634 | 0 to 749.6 K |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | Atlas Venture Fund X, L.P. | 10% Owner | Buy | C | 0.00 | 1,099,118 | 0 | 1,268,213 | 169.1 K to 1.3 M (+650.00 %) |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | Atlas Venture Fund X, L.P. | 10% Owner | Buy | C | 0.00 | 2,901,609 | 0 | 2,901,609 | 0 to 2.9 M |
| Mar 18 2021 | GBIO | Generation Bio Co. | Atlas Venture Fund X, L.P. | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 9,111,939 | 10.1 M to 9.1 M (-9.89 %) |
| Feb 22 2021 | KYMR | Kymera Therapeutic ... | Atlas Venture Fund X, L.P. | 10% Owner | Sell | J | 0.00 | 1,063,351 | 0 | 6,885,631 | 7.9 M to 6.9 M (-13.38 %) |
| Dec 17 2020 | GBIO | Generation Bio Co. | Atlas Venture Fund X, L.P. | 10% Owner | Sell | J | 0.00 | 1,151,882 | 0 | 11,478,876 | 12.6 M to 11.5 M (-9.12 %) |
| Sep 17 2020 | REPL | Replimune Group, I ... | Atlas Venture Fund X, L.P. | 10% Owner | Sell | J | 0.00 | 445,339 | 0 | 2,486,296 | 2.9 M to 2.5 M (-15.19 %) |
| Sep 17 2020 | REPL | Replimune Group, I ... | Atlas Venture Fund X, L.P. | 10% Owner | Sell | J | 0.00 | 445,339 | 0 | 2,486,296 | 2.9 M to 2.5 M (-15.19 %) |
| Aug 25 2020 | KYMR | Kymera Therapeutic ... | Atlas Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,774,624 | 0 | 0 | |
| Aug 25 2020 | KYMR | Kymera Therapeutic ... | Atlas Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,477,832 | 0 | 0 | |
| Aug 25 2020 | KYMR | Kymera Therapeutic ... | Atlas Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 7,000,000 | 0 | 0 | |
| Aug 25 2020 | KYMR | Kymera Therapeutic ... | Atlas Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 3,000,000 | 0 | 0 | |
| Aug 25 2020 | KYMR | Kymera Therapeutic ... | Atlas Venture Fund X, L.P. | 10% Owner | Buy | C | 0.00 | 1,112,686 | 0 | 1,112,686 | 0 to 1.1 M |
| Aug 25 2020 | KYMR | Kymera Therapeutic ... | Atlas Venture Fund X, L.P. | 10% Owner | Buy | C | 0.00 | 7,196,584 | 0 | 7,948,982 | 752.4 K to 7.9 M (+956.49 %) |
| Jul 07 2020 | REPL | Replimune Group, I ... | Atlas Venture Fund X, L.P. | 10% Owner | Sell | J | 0.00 | 445,339 | 0 | 2,931,635 | 3.4 M to 2.9 M (-13.19 %) |
| Jun 18 2020 | GBIO | Generation Bio Co. | Atlas Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 268,269 | 0 | 0 | |
| Jun 18 2020 | GBIO | Generation Bio Co. | Atlas Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 15,051,020 | 0 | 0 | |
| Jun 18 2020 | GBIO | Generation Bio Co. | Atlas Venture Fund X, L.P. | 10% Owner | Buy | C | 0.00 | 10,040,032 | 0 | 12,630,758 | 2.6 M to 12.6 M (+387.54 %) |
| Jun 18 2020 | REPL | Replimune Group, I ... | Atlas Venture Fund X, L.P. | 10% Owner | Sell | J | 0.00 | 445,339 | 0 | 3,376,974 | 3.8 M to 3.4 M (-11.65 %) |
| Jul 23 2019 | AVRO | AVROBIO, Inc. | Atlas Venture Fund X, L.P. | 10% Owner | Buy | P | 18.50 | 810,811 | 15,000,004 | 5,567,289 | 4.8 M to 5.6 M (+17.05 %) |
| Mar 22 2019 | MGTA | Magenta Therapeuti ... | Atlas Venture Fund X, L.P. | 10% Owner | Sell | S | 17.86 | 14,245 | 254,416 | 0 | 14.2 K to 0 (-100.00 %) |
| Mar 22 2019 | MGTA | Magenta Therapeuti ... | Atlas Venture Fund X, L.P. | 10% Owner | Buy | J | 0.00 | 14,245 | 0 | 14,245 | 0 to 14.2 K |
| Mar 22 2019 | MGTA | Magenta Therapeuti ... | Atlas Venture Fund X, L.P. | 10% Owner | Sell | J | 0.00 | 726,500 | 0 | 4,117,125 | 4.8 M to 4.1 M (-15.00 %) |
| Jul 26 2018 | REPL | Replimune Group, I ... | Atlas Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,013,547 | 0 | 0 | |
| Jul 26 2018 | REPL | Replimune Group, I ... | Atlas Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 3,439,839 | 0 | 0 | |
| Jul 26 2018 | REPL | Replimune Group, I ... | Atlas Venture Fund X, L.P. | 10% Owner | Buy | C | 0.00 | 1,013,547 | 0 | 4,453,386 | 3.4 M to 4.5 M (+29.46 %) |
| Jul 26 2018 | REPL | Replimune Group, I ... | Atlas Venture Fund X, L.P. | 10% Owner | Buy | C | 0.00 | 3,439,839 | 0 | 3,439,839 | 0 to 3.4 M |
| Jun 27 2018 | MGTA | Magenta Therapeuti ... | Atlas Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 204,339 | 0 | 0 | |
| Jun 27 2018 | MGTA | Magenta Therapeuti ... | Atlas Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 12,061,496 | 0 | 0 | |
| Jun 27 2018 | MGTA | Magenta Therapeuti ... | Atlas Venture Fund X, L.P. | 10% Owner | Buy | C | 0.00 | 4,746,876 | 0 | 4,843,625 | 96.7 K to 4.8 M (+4,906.38 %) |
| Jun 25 2018 | AVRO | AVROBIO, Inc. | Atlas Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 3,740,239 | 0 | 0 | |
| Jun 25 2018 | AVRO | AVROBIO, Inc. | Atlas Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 12,580,199 | 0 | 0 | |
| Jun 25 2018 | AVRO | AVROBIO, Inc. | Atlas Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 3,333,333 | 0 | 0 | |
| Jun 25 2018 | AVRO | AVROBIO, Inc. | Atlas Venture Fund X, L.P. | 10% Owner | Buy | C | 0.00 | 905,188 | 0 | 4,756,478 | 3.9 M to 4.8 M (+23.50 %) |
| Jun 25 2018 | AVRO | AVROBIO, Inc. | Atlas Venture Fund X, L.P. | 10% Owner | Buy | C | 0.00 | 3,044,579 | 0 | 3,851,290 | 806.7 K to 3.9 M (+377.41 %) |
| Jun 25 2018 | AVRO | AVROBIO, Inc. | Atlas Venture Fund X, L.P. | 10% Owner | Buy | C | 0.00 | 806,711 | 0 | 806,711 | 0 to 806.7 K |
Page: 1